S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Greatbatch, Inc. Reports 2014 Fourth Quarter and Full Year Results (2015/2/24)|
|Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects (2014/12/8)|
|Teva Bolsters Injectable Portfolio with Launch of Generic Lovenox® and Generic Zyvox® in the United States (2015/2/17)|
|Results from Phase III Study of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence in Patients with Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented at ASH (2014/12/8)|
|Endo Completes Acquisition of Rights to Natesto™ Testosterone Nasal Gel (2014/12/9)|
|Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant (2014/12/19)|
|AngioDynamics Receives Expanded "No Chest X-Ray" FDA Clearance for Celerity Tip Location System (2015/1/29)|
|Teleflex Launches Triple-Lumen Version of Unique ARROW® PICC with Chlorag+ard® Technology (2015/2/19)|
|ADDING MULTIMEDIA FDA Expands Indication for REVLIMID® (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly Diagnosed with Multiple Myeloma (2015/2/19)|
|FDA Expands Indication for REVLIMID® (Lenalidomide) in Combination with Dexamethasone to Include Patients Newly Diagnosed with Multiple Myeloma (2015/2/18)|
Click above to view more mutual fund data and stats for dvt - Devoteam SA.